[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Invited Critique
October 2010October 18, 2010

To Stent or Not to Stent: The Question Remains Unanswered: Comment on “Secondary Stroke Prevention in the Era of Carotid Stenting”

Author Affiliations

Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010

Arch Surg. 2010;145(10):935. doi:10.1001/archsurg.2010.192

Carotid stenting has become the “procedure du jour”; however, multiple studies and articles tout both its advantages and failures. With the rapid advancement and public acceptance of catheter-based technology, expansion into the realm of carotid revascularization was just a matter of time. The initial justification for CAS was based on the results of multiple randomized trials (the NASCET, ECST, ACAS, and ACST) that evaluated CEA with BMT. Patients who were excluded from the CEA trials as “high risk” may possibly benefit from CAS.